GE
Genprex
NASDAQ: GNPX
$0.93USD
-0.00 (-52.69%)At close: Apr 29, 11:12 UTC
Open
$0.92
Prev. Close
$0.92
High
$0.92
Low
$0.92
Key Stats
Market Cap
$2.1M
Dividend Yield
–
P/E Ratio
-0.1
EPS
-326.65
Revenue
$0
Avg. Volume
931.5K
TL;DR
Genprex's Pdx1/MafA gene therapy demonstrated success in reversing hyperglycemia in Type 2 diabetes mouse models, highlighted during the 2026 ASGCT conference.
Recently from Cashu
Genprex's Diabetes Gene Therapy Shows Promise in Preclinical Trials Ahead of ASGCT Meeting
Cashu Markets·11h ago
Genprex Unveils Promising Lung Cancer Therapy and Strategic Partnership at AACR 2026
Cashu Markets·7 days ago
Genprex: Summary Request for Specific Content Needed for Title Creation
Cashu Markets·4 months ago